The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2016

Filed:

Dec. 16, 2014
Applicant:

Cedars-sinai Medical Center, Los Angeles, CA (US);

Inventors:

Henry C. Lin, Albuquerque, NM (US);

Mark Pimentel, Los Angeles, CA (US);

Assignee:

Cedars-Sinai Medical Center, Los Angeles, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 45/00 (2006.01); A61K 47/00 (2006.01); A61K 38/54 (2006.01); A61B 5/00 (2006.01); A61K 31/353 (2006.01); A61K 31/4184 (2006.01); A61K 31/496 (2006.01); A61K 38/22 (2006.01); A61K 45/06 (2006.01); A61K 51/12 (2006.01); G01N 33/68 (2006.01); A61K 9/00 (2006.01); A61K 31/4164 (2006.01); A61K 31/43 (2006.01); A61K 31/65 (2006.01); A61K 31/7036 (2006.01); A23L 1/29 (2006.01); A61K 31/198 (2006.01); A61K 31/201 (2006.01); A61K 31/4045 (2006.01); A61B 5/083 (2006.01); G01N 33/497 (2006.01);
U.S. Cl.
CPC ...
A61K 38/54 (2013.01); A23L 1/296 (2013.01); A61B 5/412 (2013.01); A61B 5/415 (2013.01); A61B 5/418 (2013.01); A61K 9/0087 (2013.01); A61K 31/198 (2013.01); A61K 31/201 (2013.01); A61K 31/353 (2013.01); A61K 31/4045 (2013.01); A61K 31/4164 (2013.01); A61K 31/4184 (2013.01); A61K 31/43 (2013.01); A61K 31/496 (2013.01); A61K 31/65 (2013.01); A61K 31/7036 (2013.01); A61K 38/22 (2013.01); A61K 38/225 (2013.01); A61K 45/06 (2013.01); A61K 49/0004 (2013.01); A61K 51/1206 (2013.01); G01N 33/497 (2013.01); G01N 33/6893 (2013.01); A23V 2002/00 (2013.01); A61B 5/0836 (2013.01); G01N 2033/4977 (2013.01); G01N 2333/70571 (2013.01); G01N 2800/06 (2013.01); Y10S 426/80 (2013.01); Y10S 426/801 (2013.01); Y10T 436/145555 (2015.01); Y10T 436/147777 (2015.01); Y10T 436/18 (2015.01); Y10T 436/214 (2015.01); Y10T 436/22 (2015.01);
Abstract

Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.


Find Patent Forward Citations

Loading…